Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health...(. About Abbott Abbott is a...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening
Date:2/9/2009
.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 69,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.
'/>"/>
| SOURCE Abbott Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
3. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
4. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
5. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
6. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
7. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
8. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
9. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
10. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
11. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
Post Your Comments:
(Date:11/25/2009)....25/PRNewswire/--Reportlinker.comannouncesthatanew..., MammographyEquipment-AGlobalMarketPerspective...mography-Equipment---A-Global-Market-Perspective.h...alizedaswellasdevelopingnationsisaprincipalfactori...calatingawarenessaboutbreastcancerhasallowedwoment...
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...onMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT.T...reimbursementfortheCompany,sproductsandwillinclude...nswersession.Thedial-innumbersare1-877-407-4018for...
(Date:11/25/2009)...therlandsandJOHANNESBURG,November25/PRNewswire/--,...overyannouncedtoday,thattheyhavesignedacollaborati... , Pyxis,sworldclasscomputationalchemistryand...ervicedivisiontoprovidemedicinaland,syntheticchemi...nationalclientnetwork.iThembaPharmaceuticalsandPyx...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 1Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 2Kathleen Kalafs Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 54174 3Tolerx Announces Amendment to Phase 3 DEFEND Protocol 13495 1Tolerx Announces Amendment to Phase 3 DEFEND Protocol 13495 2Tolerx Announces Amendment to Phase 3 DEFEND Protocol 13495 3Genome Sequencing Gets More Affordable 54171 1Genome Sequencing Gets More Affordable 54171 2...ccess to FOSRENOL(R) and Resources f...LPHIA, April 3, 2008 Shire Pharmaceuticals, the,g...he launch of On Track,an innovative program design...mens among chronic kidney disease (CKD) Stage 5 pa...phosphorus in the blood). In addition,to offering ...
...d to Differentiate Squamous From, Non-Squamous Non...ous Cell, Carcinoma of the Lung With Sensitivity o... Percent., Accurate Diagnosis is I... Therapy for Non-Squamous NSCLC, Includes a Warnin... Hemorrhage in Patients With Squamous NSCLC ...
Other Medicine Technology:Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 2Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 3Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 4Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 5Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 6Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 PatientsColumbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...
(Date:11/25/2009).../--Thanksgivingmealswillbedeliveredtoapproximately...kstoFaithInAction/VolunteerActionforAging,aprogram...ealthPlan.Formorethan17yearstheseorganizationshave...ingmealstoseniorsinneedinLongBeach,Lakewood,Signal... ,, "Ourwarmholidaymealsaredeliveredtopeoplewho...
(Date:11/25/2009)...heBayAreaAirQualityManagementDistrictisissuingthes...t forThursday,November26,2009whichbansburningwoo...orsandoutdoors. ,, "Cold,stillweatherwillcontri...nt,executiveofficeroftheAirDistrict."We,reaskingBa...dfellowcommunitymembersthisThanksgiving,andnottobu...
(Date:11/25/2009)...tistically significant survival benefit from adjuv...or (ER)-positive tumors had high levels of phospho...-P), according to a brief communication published ... Cancer Institute . , Approximately 50% of breas...al studies have shown that ER-alpha S118-P is requ...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009[1] News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response[1] Stenting May Equal Bypass for Diabetic Heart Patients
...cting patient privacy has been recognized as the d...doctors have seen patients. In 1996 that duty beca...lth Insurance Portability and Accountability Act. ...ggregated from the medical records of vast numbers...
... Society of America is inviting all journalists t...ountry,s largest interdisciplinary conference in t...ia representatives can register free of charge. ,...ington, DC, on the shores of the Potomac River. ,...
...ogy at the systems level is difficult, especially ... or communities of organisms in a biofilm. Scienti...the molecules present in the samples. , At Georgi...ich aims to tackle these types of challenges. , "...
...why some people can,t resist paying too much at au...ews) -- The fear of losing is why people tend to o... says. , Neuroscientists and economists at New Yo...pt. 26 issue of Science . , The researchers, usin...
...tment can prevent stroke, study says , , T...ority of people at risk of stroke because the main... no symptoms are better off if they don,t have sur...sive medical therapy rather than endarterectomy [t...
...Sept. 25 Longs Drugs,(NYSE: LDG ) announced its ...n three Western states to help residents of those ...ps to combat the annual flu season. Longs is,offer...er the age of 4 by appointment or during flu clini...
Other Medicine News:Health News:Protecting patient privacy the new fashioned way 2Health News:New research on hot topics in aging to be presented at GSA's Annual Scientific Meeting 2Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 2Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 3Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 4Health News:'Fear of Losing' Key Emotion in Economic Decisions 2Health News:Surgery May Not Help Most People With Narrowed Brain Artery 2Health News:Surgery May Not Help Most People With Narrowed Brain Artery 3Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 2Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 3Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 4Protecting patient privacy the new fashioned wayNew research on hot topics in aging to be presented at GSA's Annual Scientific MeetingBio-imaging mass spectrometry techniques reveal molecular details about complex systems'Fear of Losing' Key Emotion in Economic DecisionsSurgery May Not Help Most People With Narrowed Brain ArteryLongs Drug Announces Immunization Program for the 2008/2009 Flu Season
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |